The pharmaceutical giant Glaxo Wellcome announced that it is close to identifying the human genes that make some people more susceptible to three common illnesses - migraine, adult-onset diabetes and psoriasis. A new approach to gene sequencing called single nucleotide polymorphism (SNP) mapping located the predisposition genes far quicker than was expected.
Allen Roses, vice-president and director of genetics at Glaxo Wellcome, released the findings at the annual meeting of the American Society of Human Genetics in San Francisco. The findings are the result of a collaboration between Glaxo Wellcome, Duke University, the American Diabetes Association, Griffiths University and the Swedish Psoriasis Group. 'The research we are reporting on does not mean that we can provide cures for these diseases overnight but it certainly provides us with a much better understanding of the genes involved', said Roses. 'Genetics studies of this type are extremely important in investigating the factors that underlie the development of illnesses, and revealing their root causes'.
Sources and References
-
Scientists close to finding trigger for migraines
-
Drugmaker close to naming genes for 3 ailments
Leave a Reply
You must be logged in to post a comment.